Drugs / TAK-593
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00773929 | Jan 2009 → Jan 2010 | cancer | Millennium Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-593 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00773929 ↗ |
| Modality | Small molecule | — CHEMBL2180604 ↗ |
| Route | Oral | “for oral administration” NCT00773929 ↗ |